Table 13.
NDMA | Infants (12 weeks–11 months) | Toddlers (12–35 months) | Children (3–9 years) | Adolescents (10–17 years) | Adults (18–64 years) | The elderly (≥ 65 years) |
---|---|---|---|---|---|---|
Mean exposure | 0.2–1.1 | 0.9–2.6 | 0.2–2.0 | 0.3–1.6 | 0.5–1.3 | 0.4–0.9 |
MoE | 24,500–135,000 | 10,400–30,000 | 13,500–135,000 | 16,900–90,000 | 20,800–54,000 | 30,000–67,500 |
High level exposure | 0.4–4.4 | 3.8–6.2 | 1.2–5.5 | 1.1–4.7 | 1.4–3.8 | 1.1–2.3 |
MoE | 6,100–67,500 | 4400–7,100 | 4,900–22,500 | 5,700–24,500 | 7,100–19,300 | 11,700–24,500 |
* Based on a BMDL10 of 0.027 mg/kg bw for NDEA.